Grant: Doctoral Res. Award - Pop. Genetic, Genetic Epidem. and Complex Disease
University of British Columbia
$66,000.00
Mitochondrial Genome Variation in Healthy Aging
FY 2008-09
Summary
The aim of this project is to determine whether variation in the human mitochondrial genome contributes to variability in the aging process. Our study population consists of what gerontologists refer to as the "healthy oldest old" from the Metro Vancouver area. These are individuals that have reached the upper limits of the normal human lifespan (>85 years) and have not developed any of the most common complex age-associated diseases (cancer, cardiopulmonary disease, Alzheimer disease or type II diabetes). The study is designed as a case-control genetic association study, and we will be using the most advanced DNA sequencing technology and computational power available to us at the Genome Sciences Centre to uncover genetic factors that contribute to healthy aging in our study population.
Mitochondria act as central regulators of multiple cellular processes including intermediary metabolism, calcium signaling, and apoptosis. Mitochondria are also the primary source of reactive oxygen species that damage proteins and lipids, and can cause mutations in DNA. Heritability studies have shown that the heritability of human longevity has a larger maternal component than paternal component. Since the mitochondrial genome is inherited through the maternal side, this is evidence that the mitochondrial genome plays some role in the aging process. Other studies have shown associations between human lifespan and specific variants in the mitochondrial genome.
The Genome Sciences Centre at the BC Cancer Agency is home to some of the world's most advanced DNA sequencing equipment, including several illumina Genome Analyzer machines that are capable of producing over 1 billion bases of sequence data in a single run. We will collaborate with a senior biostatistician at the BC Cancer Agency to use the latest non-parametric statistical techniques to model the impact of sequence variation in the mitochondrial genome on the development of the healthy aging phenotype being studied.
Department
Program
Doctoral Res. Award - Pop. Genetic, Genetic Epidem. and Complex Disease
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
183964
Name
Fornika Daniel J
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Mitochondrial Genome Variation in Healthy Aging
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$66,000
Cihrequipment2
$0
Programname2
Doctoral Res. Award - Pop. Genetic, Genetic Epidem. and Complex Disease
Keyworddelim
Aging; Genetics; Mitochondria
Abstract
The aim of this project is to determine whether variation in the human mitochondrial genome contributes to variability in the aging process. Our study population consists of what gerontologists refer to as the "healthy oldest old" from the Metro Vancouver area. These are individuals that have reached the upper limits of the normal human lifespan (>85 years) and have not developed any of the most common complex age-associated diseases (cancer, cardiopulmonary disease, Alzheimer disease or type II diabetes). The study is designed as a case-control genetic association study, and we will be using the most advanced DNA sequencing technology and computational power available to us at the Genome Sciences Centre to uncover genetic factors that contribute to healthy aging in our study population.
Mitochondria act as central regulators of multiple cellular processes including intermediary metabolism, calcium signaling, and apoptosis. Mitochondria are also the primary source of reactive oxygen species that damage proteins and lipids, and can cause mutations in DNA. Heritability studies have shown that the heritability of human longevity has a larger maternal component than paternal component. Since the mitochondrial genome is inherited through the maternal side, this is evidence that the mitochondrial genome plays some role in the aging process. Other studies have shown associations between human lifespan and specific variants in the mitochondrial genome.
The Genome Sciences Centre at the BC Cancer Agency is home to some of the world's most advanced DNA sequencing equipment, including several illumina Genome Analyzer machines that are capable of producing over 1 billion bases of sequence data in a single run. We will collaborate with a senior biostatistician at the BC Cancer Agency to use the latest non-parametric statistical techniques to model the impact of sequence variation in the mitochondrial genome on the development of the healthy aging phenotype being studied.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Fornika, Daniel J
Approvedterm
3 ans 0 mois
Cihrcontribution2
Institute of Genetics~ $66,000~ $0~